Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cell-free DNA for the detection of pancreatic, liver and upper gastrointestinal cancers: has progress been made?

Future oncology (London, England) - 1 Dec 2013

Gall Tamara M H, Frampton Adam E, Krell Jonathan, Habib Nagy A, Castellano Leandro, Stebbing Justin, Jiao Long R

Abstract excerpt

Detecting alterations in blood cell-free DNA (cfDNA) is hoped to be a novel, noninvasive method for diagnosing, prognosing and monitoring cancer patients. Several studies have assessed the usefulness of measuring tumor-specific genetic and epigenetic changes of cfDNA, such as loss of heterozygosity, frequency of mutations, alterations of microsatellites and the methylation of genes in patient blood samples....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Gastrointestinal Neoplasms

Share to Liver Neoplasms

Share to Mutation

Share to Pancreatic Neoplasms

Share to Promoter Regions, Genetic

Source

Identifiers

PMID: 24295416
DOI: 10.2217/fon.13.152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cell-free DNA for the detection of pancreatic, liver and upper gastrointestinal cancers: has progress been made?PMID 24295416Read ↗

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic CancerSemantic proximity Read ↗

Cell-free DNA as a diagnostic marker for cancer: current insightsSemantic proximity Read ↗

Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer ManagementSemantic proximity Read ↗

Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsiesSemantic proximity Read ↗

Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma—A Literature UpdateSemantic proximity Read ↗

Cell-Free DNA: Hope and Potential Application in CancerSemantic proximity Read ↗

The emerging role of cell-free DNA as a molecular marker for cancer managementSemantic proximity Read ↗

Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysisSemantic proximity Read ↗

Circulating cell‐free <scp>DNA</scp> methylation‐based multi‐omics analysis allows early diagnosis of pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlationsSemantic proximity Read ↗

The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian CancerSemantic proximity Read ↗

Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.